Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Anxiety & depression could surge in 2023
With markets, economy, and just all the craziness going on there no doubt we should see real crisis in anxiety and depression.
This only increases EHVVF business outlook.
You get some traders who suffer from anxiety to buy stock that would send EHVVF running for so many suffer from that and depression.
RoomMate fall detection sensor
Posted on MLRT website
https://metalert.com/roommate-wearable-alert-system/
Ehave at Web3 Summit (new tweets)
Company is starting to show life with focus on health data and web3
MetaHealthU = health data management
Building data sets up patient health that could be sold to biotech firms doing clinical trials for become big money for EHVVF
.49 is about to fall
This breaks into .50s this could take off
ELEK not debt risk
+42%
Break .50 and this could set stage for run to $1.00+
EHVVF Healthcare data management
MLRT running +42% on big news
https://www.cnbc.com/quotes/MLRT
MLRT running +42% on big news
https://www.cnbc.com/quotes/MLRT
Ask .0065
starting to breakout
EHVVF (006) business will boom in recession
As economy tanks cases of anxiety and depression will spike.
This will only increase demand for Ehave (OTC:EHVVF) business of psychedelic and mobile apps for treatment of anxiety & depression
https://www.otcmarkets.com/stock/ehvvf/quote
EHVVF (006) business will boom in recession
As economy tanks cases of anxiety and depression will spike.
This will only increase demand for Ehave (OTC:EHVVF) business of psychedelic and mobile apps for treatment of anxiety & depression
https://www.otcmarkets.com/stock/ehvvf/quote
$1.25 price target
(NEW YORK)–MetAlert, Inc. (OTC:MLRT) issued positive guidance for their NFC operations, and receipt of new chip shipments, which should result in ramp-up production of their GPS SmartSole’s for backlog sales orders now in the thousands of units.
For the three-month period ending Sept 30, 2022, the company reported revenues of $67,653, which according to the company was attributed to continue chip shortages for SmartSole unit production.
Although disappointing, production and sales for SmartSole’s may be about to ramp-up significantly in the near-term as company has begun receiving new chip deliveries in Q4, with even higher deliveries of these chips expected in Q1 2023.
These chips will now allow them to produce new SmartSole units to fulfill backorders now in the thousands, which could result in a sharp increase in sales revenue in the coming weeks to month.
The Company quoted in their recent 10Q, “This situation has created a significant backlog of orders, which we expect to fulfil over the coming months. We have raw component inventory to make several thousand units, which is still below what we need in total to fulfil backorders but as the supply chain issues improve, we expect to be able to order additional components with shorter lead times starting early next year.”
POSITIVE GUIDANCE ON NFC BUSINESS
The Company issued guidance on this business segment stating, “our NFC/NFT business has been increasing, and we saw a 342% increase over the second quarter, and expect this business unit to continue to grow. It is a part of our business we are looking to expand as it is not so much reliant on supply chain issues and component sourcing. We believe by adding three or four more customers like endstate, and this could become a strong source of revenue for us.”
CUSTOMER EXPANSION
As part of the rebranding, the Company will be expanding its product line and will no longer merely sell tracking solutions, but rather more comprehensive remote patient monitoring solutions. New products will include fall detection, biometrics, analytics, telehealth, and a host of other related medical services. We plan to also grow horizontally and expand our target audience beyond seniors with Alzheimer’s or dementia, or children with autism.
SUMMARY
Although Q3 2022 revenues came in softer than expected, the influx of new chips in Q4, and Q1 2023, should result in the ramp-up of SmartSole unit production in the near-term. This increase in production capacity should allow them to fulfill thousands of backlog unit orders in place, which should result in significant increase in sales revenue in coming weeks and months. The Company no longer holds any toxic notes, and took on no new convertible debt during the quarter.
Ludlow Research maintains its speculative short-term target on MLRT of $1.00 to $1.25 per share.
https://ludlowresearch.com/metalert-mlrt-to-fulfill-backorders-issues-positive-guidance-nfc-business/
Ehave mushroom sales
Last year was different market
What you saw last year you may not see again in your life, or least not in another 25 years like dotcom liquidity run. That was due to 0% interest rates and that just is not coming back.
But, I do agree they need to appoint a real team. Get some project heads and people with real EV background and this will take off.
EHVVF 10% discount for Thanksgiving!!!
Ask .006 now
Only 97,000 shares left @ .0055
MLRT discusses Canadian deal
Sell NFT data for biotech firms
$MLRT .40 issued $1.25+ price target
$MLRT .40 issued $1.25+ price target
21663 shares @ .40
Break that wall and this goes. Probably bet lot that will jump away once slapped
Issues bullish guidance on NFC business
Several thousand in backorders
That was good corporate update (video)
Merger S-4 could get approved soon
Now every deal is different, but on average a normal registration statement can take around 4 months to go through comments with SEC before approval.
Since TPIA NASDAQ merger filing was filed in August we should be getting close to that.
https://www.sec.gov/cgi-bin/browse-edgar?company=PSLY.COM
Never know when could hit for when does this could rocket to $1.00+ wicked fast with low float....so loading up anything under .30 is a gift here
$TPIA (.20) mushrooms, NASDAQ merger (1m shr float)
Float only 1m shares.....NASDAQ up listing merger coming
https://finance.yahoo.com/news/ehave-announces-mycotopia-therapies-reaches-130000386.html
$TPIA (.20) mushrooms, NASDAQ merger priced $1.56
Float only 1m shares.....NASDAQ up listing merger coming
https://finance.yahoo.com/news/ehave-announces-mycotopia-therapies-reaches-130000386.html
ELEK needs EV partner like Pininfarina
Look at the car
I just saw volume
New tweets and volume picking up.
Now like to see that spill over to $TPIA for that S-4 merger deal is moving closer to closing
$ELEK .09 closing EV deal with Italian car maker
Very tight float
https://www.cnbc.com/quotes/ELEK
$ELEK .09 closing EV deal with Italian car maker
Very tight float
https://www.cnbc.com/quotes/ELEK
Look at Pininfarina cars, WOW!
https://www.automobili-pininfarina.com/battista
NEWS OUT!
Elektros Initiates Discussions with Italian Luxury Car Design Firm Pininfarina
SUNNY ISLES BEACH, FL / ACCESSWIRE / November 16, 2022 / Elektros (OTC PINK:ELEK), an emerging leader in the electric mobility industry, announced it has begun talks with Pininfarina, one of Italy's premier luxury car design and production companies.
Elektros is excited to announce it has begun talks with Italian luxury car design firm Pininfarina.
Founded in 1930, Pininfarina S.p.A. is an Italian luxury car design firm headquartered in Cambiano, Italy.
Pininfarina engages in the design, engineering, and sales of spare parts and prototypes in Italy, Germany, China, and the United States through its Design and Engineering segments. The Company provides aerodynamic and aeroacoustics, automotive engineering, bespoke, and wind tunnel services, and primarily serves automotive, vehicle production, transportation.
Their Battista hyper GT is the first in a range of purely electric, zero-emissions, luxury cars solely branded Pininfarina, with top speed of 270 mph and range of 310 mile on single charge.
Tweet, signs of life (photos)
Ehave $EHVVF had great time attending, and bringing the CureDash van, to the #Microdose Wonderland conference in Miami early this month#psychedelics #anxiety #despression #PTSD pic.twitter.com/9mqCaJtpHN
— Ehaveinc $EHVVF (@Ehaveinc1) November 15, 2022